Recombinant bacterial β-galactosidases for lactose bioconversion and galacto-oligosaccharide production: a comparative overview
4 affiliations
- 1Laboratory for Genetics and Biochemistry of Microorganisms, National Center for Biotechnology, Astana, Kazakhstan
- 2Institute of Engineering and Food Technology, S. Seifullin Kazakh Agrotechnical Research University, Astana, Kazakhstan
- 3Department of General Biology and Genomics, Institute of Natural Sciences, L.N. Gumilyov Eurasian National University, Astana, Kazakhstan
- 4Corporate Development and Strategy Department, S. Seifullin Kazakh Agrotechnical Research University, Astana, Kazakhstan
Abstract
The increasing demand for lactose-free dairy products, sustainable whey valorization and high-value prebiotic ingredients has intensified the need for efficient bacterial β-galactosidases capable of both lactose hydrolysis and galacto-oligosaccharide (GOS) synthesis. Although numerous bacterial β-galactosidases have been identified and recombinantly produced, information on their structural characteristics, catalytic properties, recombinant production efficiency and performance under application-relevant conditions remains scattered across individual studies, complicating their comparative evaluation for specific biotechnological applications. This review presents a comprehensive comparative overview of recombinant bacterial β-galactosidases with particular emphasis on their potential for lactose bioconversion and GOS production. Current knowledge on enzyme diversity, glycoside hydrolase families, structural organization, molecular determinants of catalysis, recombinant expression systems, purification strategies, hydrolytic activity and transglycosylation capacity is critically evaluated together with recent advances in protein engineering, computational enzyme design and commercially available β-galactosidase preparations. Comparative analysis of published studies indicates that catalytic efficiency alone is insufficient to assess the potential suitability of β-galactosidases for industrial applications. Enzyme performance is influenced by the combined effects of molecular architecture, catalytic properties, recombinant production efficiency, thermostability, product inhibition and transglycosylation capacity. However, direct comparisons remain limited by differences in experimental conditions and by the relatively small number of studies conducted in real dairy matrices or under industrially relevant process conditions. Accordingly, this review compares the major biochemical, molecular, recombinant production and process-related factors that should be considered when evaluating β-galactosidases for lactose hydrolysis, GOS production and large-scale bioprocessing. Particular attention is given to the current limitations in translating laboratory-scale enzyme characterization into industrial application, including limited validation in complex dairy matrices, regulatory considerations, scalable catalyst configurations and downstream processing requirements. Current limitations of commercial β-galactosidase preparations and future opportunities offered by protein engineering, artificial intelligence-assisted enzyme discovery and structure-guided design are also discussed. Overall, this review provides a comparative perspective on recombinant bacterial β-galactosidases and identifies the principal factors influencing their potential application in lactose bioconversion and GOS production, while highlighting the need for further validation under application-relevant and industrial-scale conditions.
Related
- Recombinant Expression and Functional Analysis of GH2 β-Galactosidases Derived from Lactobacillus delbrueckii subsp. bulgaricus NSP1 and Streptococcus thermophilus RB16
- Comparative effects of Mannan oligosaccharide, synbiotic, and their combination on growth performance and intestinal health in broiler chickens
- Comparative Transcriptomic Profiling of Diabetic Wound Responses to Recombinant Periplaneta americana Thymosin Isoforms in Male ob/ob Mice
- A biosensor toolbox for monitoring recombinant protein production in Escherichia coli.
- Comparison of Wildtype and Recombinant Adeno-Associated Virus (AAV) Production Reveals Distinct Productivity and Content Ratio Profiles.
BibTeX
@article{kostanova2026recombinant,
title = {{Recombinant bacterial β-galactosidases for lactose bioconversion and galacto-oligosaccharide production: a comparative overview}},
author = {Anel Kostanova and Yuliya Shamsiyeva and Zhiger Akishev and Bekbolat Khassenov and Annelya Tursunbekova},
journal = {Frontiers in Microbiology},
year = {2026},
month = oct,
doi = {10.3389/fmicb.2026.1943869},
url = {https://doi.org/10.3389/fmicb.2026.1943869},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Recombinant bacterial β-galactosidases for lactose bioconversion and galacto-oligosaccharide production: a comparative overview
AU - Anel Kostanova
AU - Yuliya Shamsiyeva
AU - Zhiger Akishev
AU - Bekbolat Khassenov
AU - Annelya Tursunbekova
PY - 2026
DA - 2026/10/12
JO - Frontiers in Microbiology
DO - 10.3389/fmicb.2026.1943869
UR - https://doi.org/10.3389/fmicb.2026.1943869
AB - The increasing demand for lactose-free dairy products, sustainable whey valorization and high-value prebiotic ingredients has intensified the need for efficient bacterial β-galactosidases capable of both lactose hydrolysis and galacto-oligosaccharide (GOS) synthesis. Although numerous bacterial β-galactosidases have been identified and recombinantly produced, information on their structural characteristics, catalytic properties, recombinant production efficiency and performance under application-relevant conditions remains scattered across individual studies, complicating their comparative evaluation for specific biotechnological applications. This review presents a comprehensive comparative overview of recombinant bacterial β-galactosidases with particular emphasis on their potential for lactose bioconversion and GOS production. Current knowledge on enzyme diversity, glycoside hydrolase families, structural organization, molecular determinants of catalysis, recombinant expression systems, purification strategies, hydrolytic activity and transglycosylation capacity is critically evaluated together with recent advances in protein engineering, computational enzyme design and commercially available β-galactosidase preparations. Comparative analysis of published studies indicates that catalytic efficiency alone is insufficient to assess the potential suitability of β-galactosidases for industrial applications. Enzyme performance is influenced by the combined effects of molecular architecture, catalytic properties, recombinant production efficiency, thermostability, product inhibition and transglycosylation capacity. However, direct comparisons remain limited by differences in experimental conditions and by the relatively small number of studies conducted in real dairy matrices or under industrially relevant process conditions. Accordingly, this review compares the major biochemical, molecular, recombinant production and process-related factors that should be considered when evaluating β-galactosidases for lactose hydrolysis, GOS production and large-scale bioprocessing. Particular attention is given to the current limitations in translating laboratory-scale enzyme characterization into industrial application, including limited validation in complex dairy matrices, regulatory considerations, scalable catalyst configurations and downstream processing requirements. Current limitations of commercial β-galactosidase preparations and future opportunities offered by protein engineering, artificial intelligence-assisted enzyme discovery and structure-guided design are also discussed. Overall, this review provides a comparative perspective on recombinant bacterial β-galactosidases and identifies the principal factors influencing their potential application in lactose bioconversion and GOS production, while highlighting the need for further validation under application-relevant and industrial-scale conditions.
SN - 1664-302X
ER -